| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |